A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)
Clinical trial NCT03480802 · COMPLETED
Trial details
- NCT number
- NCT03480802
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-06
- Primary completion
- 2019-09-16
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.